Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study

Heart, Artery and Coronary Diseases

Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS)

Am Heart J

Gibson CM, Bahit MC, Mehran R, Mehta SR, Lamee RA, Goto S, Weitz JI, Horrow J, Barnathan ES, Harrington RA, Mahaffey KW, Lam CSP, Pieper KS, Johnston SC, Hankey GJ, Plotnikov AN, Li D, Deng H, Steg PG, Librexia ACS Committees and Investigators.

doi: 10.1016/j.ahj.2025.02.011

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Society Guidelines on Trends in Use of Newer P2Y(12) Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

J Am Heart Assoc

Mohamed MO, Kontopantelis E, Alasnag M, Abid L, Banerjee A, Sharp ASP, Bourantas C, Sirker A, Curzen N, Mamas MA

doi: 10.1161/JAHA.124.034414

Heart, Artery and Coronary DiseasesTherapy and Intervention

Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial

J Am Coll Cardiol

Alshahrani NS, Hartley A, Howard J, Hajhosseiny R, Khawaja S, Seligman H, Akbari T, Alharbi BA, Bassett P, Al-Lamee R, Francis D, Kaura A, Kelshiker MA, Peters NS, Khamis R

doi: 10.1016/j.jacc.2024.03.398

Heart, Artery and Coronary Diseases

Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study

Eur Heart J

Roman M, Miksza J, Lai FY, Sze S, Poppe K, Doughty R, Squire I, Murphy GJ

doi: 10.1093/eurheartj/ehae755

Heart, Artery and Coronary Diseases

Optimisation of care among patients with diabetes mellitus and acute coronary syndrome through a specialised cardiodiabetes service-A registry study

Diabet Med

Shah MU, Roebuck A, Srinivasan B, Squires PE, Hills CE, Inghels M, Lee K

doi: 10.1111/dme.70030

Further Publications

Proenkephalin Improves Cardio-Renal Risk Prediction in Acute Coronary Syndromes: The KID-ACS Score

Eur Heart J

Wenzl FA, Wang P, Arrigo M, Parenica J, Jones DJL, Bruno F, Tarnwski D, Hartmann O, Boucek L, Lang F, Obeid S, Schober A, Kraler S, Akhmedov A, Kahles F, Schober A, Ow KW, Ministrini S, Camici GG, Bergmann A, Liberale L, Jarkovsky J, Schweiger V, Sandhu JK, von Eckardstein A, Templin C, Muller O, Ondrus T, Olic JJ, Roffi M, Räber L, Cao TH, Jungbauer CG, Ng LL, Mebazaa A, Lüscher TF

doi: 10.1093/eurheartj/ehae602

Heart, Artery and Coronary DiseasesTherapy and Intervention

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers After Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study

J Am Heart Assoc

Barry AR, Helisaz H, Safari A, Loewen P

doi: 10.1161/JAHA.124.035215

Therapy and Intervention

Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study

JACC Cardiovasc Interv

den Dekker WK, Elscot JJ, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM, Diletti R, BIOVASC Investigators

doi: 10.1016/j.jcin.2024.09.058

Heart, Artery and Coronary Diseases

Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromes

Eur J Clin Invest

van der Stouwe JG, Godly K, Kraler S, Godly J, Matter CM, Wenzl FA, von Eckardstein A, Räber L, Mach F, Obeid S, Templin C, Lüscher TF, Niederseer D, SPUM‐ACS investigators

doi: 10.1111/eci.14314

Related content

Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS)

Impact of Society Guidelines on Trends in Use of Newer P2Y(12) Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial

Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study

Optimisation of care among patients with diabetes mellitus and acute coronary syndrome through a specialised cardiodiabetes service-A registry study

Proenkephalin Improves Cardio-Renal Risk Prediction in Acute Coronary Syndromes: The KID-ACS Score

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers After Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study

Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study

Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromes